Sharon Dowell

ORCID: 0000-0002-6655-2161
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research
  • Systemic Lupus Erythematosus Research
  • Interprofessional Education and Collaboration
  • Hepatitis C virus research
  • Long-Term Effects of COVID-19
  • Eosinophilic Disorders and Syndromes
  • COVID-19 Clinical Research Studies
  • Lymphoma Diagnosis and Treatment
  • Osteoarthritis Treatment and Mechanisms
  • Innovations in Medical Education
  • Cardiac electrophysiology and arrhythmias
  • Vitamin C and Antioxidants Research
  • Mycobacterium research and diagnosis
  • Calcium signaling and nucleotide metabolism
  • Medicine and Dermatology Studies History
  • Diversity and Career in Medicine
  • Rhetoric and Communication Studies
  • Gout, Hyperuricemia, Uric Acid
  • Inflammatory Myopathies and Dermatomyositis
  • Inflammatory Bowel Disease
  • Musculoskeletal Disorders and Rehabilitation
  • Family and Patient Care in Intensive Care Units
  • Delphi Technique in Research
  • Drug-Induced Ocular Toxicity

NEA Baptist Memorial Hospital
2024

Fairfield Medical Center
2023

University of North Carolina Health Care
2023

Georgetown University
2023

Ohio University
2023

Howard University
2015-2023

American College of Rheumatology
2023

MGH Institute of Health Professions
2022

Howard University Hospital
2013-2020

University of the West Indies System
2013

Objective Our objective was to evaluate the factors associated with regional variation of rheumatoid arthritis (RA) disease burden in US. Methods In a retrospective cohort analysis Rheumatology Informatics System for Effectiveness (RISE) registry data, seropositivity, RA activity (Clinical Disease Activity Index [CDAI], Routine Assessment Patient Data–version 3 [RAPID3]), socioeconomic status (SES), geographic region, health insurance type, and comorbidity were recorded. An Area Deprivation...

10.1002/acr2.11532 article EN cc-by-nc-nd ACR Open Rheumatology 2023-02-21

Objective Recent evidence suggests that hydroxychloroquine use is not associated with higher 1‐year risk of long QT syndrome (LQTS) in patients rheumatoid arthritis (RA). Less known about its long‐term risk, the examination which was objective this study. Methods We conducted a propensity score–matched active‐comparator safety study 8,852 veterans (mean age 64 ± 12 years, 14% women, 28% Black) newly diagnosed RA. A total 4,426 started on and another nonbiologic disease‐modifying...

10.1002/acr.25005 article EN Arthritis Care & Research 2022-08-30

Health care distance simulation (HCDS) replicates professional encounters through an immersive experience overseen by experts and in which technological infrastructure enriches the learning activity. As HCDS has gained traction, so movement to provide inclusive accessible experiences for all participants. However, established guidelines best practices regarding justice, equity, diversity, inclusion (JEDI) are lacking. This study aimed generate consensus statements on JEDI principles...

10.1097/acm.0000000000005317 article EN Academic Medicine 2023-07-11

Introduction Systemic lupus erythematosus (SLE) is highly prevalent in the Caribbean, with limited access to specialist care. Primary care providers (PCPs) must play a key role SLE management but lack specific knowledge on high-impact diagnostic and strategies for Caribbean patient. The Association Rheumatology (CAR) supports PCPs educational material tailored by poor regional data needs. aim of this project was achieve consensus amongst CAR members priorities based individual experience....

10.3389/flupu.2024.1446335 article EN cc-by Frontiers in Lupus 2024-09-16

To evaluate the regional variation of cost sharing and associations with rheumatoid arthritis (RA) disease burden in US.Patients RA from rheumatology practices Northeast, South, West US regions were evaluated. Sociodemographics, status, comorbidities collected, Rheumatic Disease Comorbidity Index (RDCI) score was calculated. Primary insurance types copay for office visits (OVs) medications documented. Univariable pairwise differences between conducted, multivariable regression models...

10.1002/acr2.11575 article EN cc-by-nc ACR Open Rheumatology 2023-06-19

Disclosure Form Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by authors. Any queries (other than missing content) should be directed to corresponding author article.

10.1002/art.42373 article EN Arthritis & Rheumatology 2022-09-30

<h3>Background</h3> Hyperuricemia is common and along with comorbidities, increasing in prevalence. Though often asymptomatic hence, under diagnosed, it may be associated subclinical urate deposition. Ultrasound (US) imaging can detect deposition individuals hyperuricemia (ASU). <h3>Objectives</h3> To evaluate the association of comorbidities via US ASU. <h3>Methods</h3> ASU was defined as serum (sUA) &gt;6 mg/dl; sUA &lt;6 mg/dl served controls. Demographic (age, gender, BMI), comorbidity...

10.1136/annrheumdis-2018-eular.2959 article EN Annals of the Rheumatic Diseases 2018-06-01

The COVID-19 outbreak emerged in December 2019 and has rapidly become a global pandemic. A great deal of effort been made to find effective drugs against this disease. Chloroquine (CQ) hydroxychloroquine (HCQ) have demonstrated promise treating COVID-19. CQ/HCQ used prevent treat malaria are efficacious anti-inflammatory agents rheumatoid arthritis systemic lupus erythematosus. These potential broad-spectrum antiviral properties, widely adopted for treatment clinical trials. In review, we...

10.22541/au.158872324.45525940 preprint EN cc-by Authorea (Authorea) 2020-05-06

Background Ethnic minority (EM) patients with Rheumatoid Arthritis (RA) have more severe disease, disability, and less use of biologic disease modifying anti-rheumatic drugs (bDMARDs). A Treat to target (T2T) strategy has been recommended improve clinical outcomes but barriers include patient preference, access specialty care increased administrative effort. Additionally, EM in the US often low health literacy, express greater reluctance accept physician recommendations, part due...

10.1136/annrheumdis-2022-eular.3745 article EN Annals of the Rheumatic Diseases 2022-05-23

<h3>Background</h3> RCT are the gold standard for therapeutic efficacy, yet many studies indicate most patients seen in routine clinical care do not meet inclusion criteria.<sup>1</sup> Apart from cultural challenges to enrollment of ethnic minorities studies, decreased access and care, late presentation disease course may preclude RA RCT. However, eligibility RCT, best our knowledge, has been reported <h3>Objectives</h3> To evaluate criteria a cohort minority patients. <h3>Methods</h3>...

10.1136/annrheumdis-2013-eular.1255 article EN Annals of the Rheumatic Diseases 2013-06-01

<h3>Background</h3> Cardiovascular (CVD) comorbidity and mortality in rheumatoid arthritis (RA), is well documented.<sup>1</sup> Increased prevalence of the metabolic syndrome, higher disease activity, greater prednisone less DMARD usage are established contributors. RA patients frequently evaluated for CVD risk factors<sup>2</sup>. Yet, ethnic minorities have a factors events. <h3>Objectives</h3> To evaluate scores minority patients. <h3>Methods</h3> Enrolled, consented EMRAC were...

10.1136/annrheumdis-2013-eular.2551 article EN Annals of the Rheumatic Diseases 2013-06-01

<h3>Background</h3> Comorbities, advanced age, and prednisone usage are known risk factors for infection in RA patients who already have compromised immune systems. However, both the ethnic minorities with utility of biologic use as a predictor unknown. <h3>Objectives</h3> To evaluate scores (IRS)<sup>1</sup> diverse minority cohort, effect therapy. <h3>Methods</h3> Enrolled, consented EMRAC were evaluated. IRS measures including socio-demographic (age), previous patient-reported serious...

10.1136/annrheumdis-2013-eular.2550 article EN Annals of the Rheumatic Diseases 2013-06-01

<h3>Background</h3> Comorbidity is common in ethnic patients with rheumatoid arthritis (RA) and often impact choice of DMARD therapy clinical outcomes. In addition to simple summation comorbidities, composite indices have been proffered as better predictors poor outcomes arthritis<sup>1</sup>. However, their applicability RA subsets unknown. <h3>Objectives</h3> To compare mean comorbidity arthritis. <h3>Methods</h3> Patients enrolled the Ethnic Minority Consortium (EMRAC), at least 6 months...

10.1136/annrheumdis-2017-eular.5842 article EN Annals of the Rheumatic Diseases 2017-06-01
Coming Soon ...